Developmental immunotoxicity (DIT) testing of pharmaceuticals: Current practices, state of the science, knowledge gaps, and recommendations

By Collinge Mark   Burns-Naas Leigh Ann   Chellman Gary J.   Kawabata Thomas T.   Komocsar Wendy J.   Piccotti Joseph R.   Shenton Jacintha   Wierda Daniel  

Journal of Immunotoxicology, Vol. 9, Iss. 2, 2012-06 ,pp. : 210-230

Informa Healthcare

Access to resources Recommend Favorite

Immunotoxicity profile of natalizumab

By Wehner Nancy   Gasper Carolyn   Shopp George   Nelson Joyce   Draper Ken   Parker Suezanne   Clarke Janet  

Journal of Immunotoxicology, Vol. 6, Iss. 2, 2009-04 ,pp. : 115-129

Informa Healthcare

Access to resources Recommend Favorite

The Role of Histopathology in the Identification of Immunotoxicity

By Haley Patrick  

Journal of Immunotoxicology, Vol. 2, Iss. 4, 2005-10 ,pp. : 181-183

Informa Healthcare

Access to resources Recommend Favorite

Influence of melatonin on immunotoxicity of lead

By Kim  

International Journal of Immunopharmacology, Vol. 22, Iss. 10, 2000-10 ,pp. : 821-832

Elsevier

Access to resources Recommend Favorite

Immunotoxicity Testing in Non-Rodent Species

By Haggerty Helen G.  

Journal of Immunotoxicology, Vol. 4, Iss. 2, 2007-04 ,pp. : 165-169

Informa Healthcare

Access to resources Recommend Favorite